On and effective August 18, 2021, Kevin B. Churchwell, M.D., resigned from the board of directors of Cyclerion Therapeutics, Inc. (the “Company”). Dr. Churchwell did not advise the Company of any disagreement with the Company on any matter
relating to its operations, policies or practices.
Marsha Fanucci, the Chair of the Company’s Board of Directors, noted: “I would like to sincerely thank Kevin for his years of service on the Board. We have accepted Kevin’s resignation, made in light of his expanded responsibilities and new
position as President and Chief Executive Officer of Boston Children’s Hospital.”
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cyclerion Therapeutics, Inc.
Dated: August 19, 2021
Chief Financial Officer
makes a similar move, sign up!
Other recent filings from the company include the following:
Current report, items 7.01 and 9.01
- Sept. 30, 2021